Titelia

Fund shareholders of Outlook Therapeutics Inc

ISIN US69012T3059 · United States · LEI 5493007AWUJ6HPMCBH11

Fund shareholders
10
Of which ETFs
0 10 other funds
Value held
≈ 7.9M $ 7.3M $ · 459.1K €
Share of capital
2.0 % of 243.4M shares on Aug 14, 2026
Sold short
0.6 % by 1 fund, as of Aug 20, 2026
FundSharesValueWeight in fundShare of capital
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS 3,069,2954.9M $0.00 %1.26 %as of Jun 30, 2026 ↗
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS 1,231,8512M $0.00 %0.51 %as of Jun 30, 2026 ↗
Fidelity Extended Market Index Fund Fidelity Concord Street Trust 382,684279.4K $0.00 %0.16 %as of May 31, 2026 ↗
Fidelity Total Market Index Fund Fidelity Concord Street Trust 57,55742K $0.02 %as of May 31, 2026 ↗
Fidelity Series Total Market Index Fund Fidelity Concord Street Trust 52,92938.6K $0.02 %as of May 31, 2026 ↗
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS 46,10673.3K $0.00 %0.02 %as of Jun 30, 2026 ↗
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS 29,62047.1K $0.00 %0.01 %as of Jun 30, 2026 ↗
Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust 7,5745.5K $0.00 %as of May 31, 2026 ↗
Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III 603588.9 $0.00 %0.00 %as of Jul 31, 2026 ↗
ABANTE QUANT VALUE, F.I. ABANTE ASESORES GESTION, SGIIC, S.A. 459.1K €2.45 %as of Dec 31, 2025 ↗

Download this table: CSV, JSON

Report an error

The funds most exposed to it

The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.

FundWeight in fund
ABANTE QUANT VALUE, F.I. ABANTE ASESORES GESTION, SGIIC, S.A. 2.45 %as of Dec 31, 2025 ↗
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS 0.00 %as of Jun 30, 2026 ↗
Fidelity Extended Market Index Fund Fidelity Concord Street Trust 0.00 %as of May 31, 2026 ↗
Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III 0.00 %as of Jul 31, 2026 ↗
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS 0.00 %as of Jun 30, 2026 ↗
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS 0.00 %as of Jun 30, 2026 ↗
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS 0.00 %as of Jun 30, 2026 ↗

Quarter after quarter

Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.

QuarterShareholdersChangeSharesChange
2026Q3904,878,219+104.9 %
2026Q29-22,381,053+43.4 %
2026Q111+11,660,745+11.0 %
2025Q410-241,496,212-10.7 %
2025Q334-371,674,869-19.2 %
2025Q271+22,072,053+11.0 %
2025Q169-61,867,329-1.2 %
2024Q475+61,890,237+70.6 %
2024Q369+191,108,167+50.1 %
2024Q250738,138

Short sellers of Outlook Therapeutics Inc

Regulators publish the open short positions in this company. Titelia read them from quivad on Aug 20, 2026: today's figure

SellerPositionDisclosed on
Bronte Capital Management Pty Ltd0.6 %Jun 28, 2024

Institutional managers

50 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.

ManagerSharesValue
ARMISTICE CAPITAL, LLC4,168,000857.8K $as of Mar 31, 2026
GEODE CAPITAL MANAGEMENT, LLC603,606124.2K $as of Mar 31, 2026
GILPIN WEALTH MANAGEMENT, LLC600,162123.5K $as of Mar 31, 2026
BlackRock, Inc.477,47198.3K $as of Mar 31, 2026
COMMONWEALTH EQUITY SERVICES, LLC470,00096.7K $as of Mar 31, 2026
Warberg Asset Management LLC275,00056.4K $as of Mar 31, 2026
RENAISSANCE TECHNOLOGIES LLC255,15752.5K $as of Mar 31, 2026
NINE MASTS CAPITAL Ltd232,54647.9K $as of Mar 31, 2026
Connective Capital Management, LLC200,00041.2K $as of Mar 31, 2026
STATE STREET CORP163,10233.6K $as of Mar 31, 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLP134,08427.6K $as of Mar 31, 2026
UBS Group AG133,06927.4K $as of Mar 31, 2026
SIMPLEX TRADING, LLC132,66627.3K $as of Mar 31, 2026
GROUP ONE TRADING LLC113,70123.4K $as of Mar 31, 2026
Virtu Financial LLC112,78623 $as of Mar 31, 2026
HRT FINANCIAL LP67,75913 $as of Mar 31, 2026
NORTHERN TRUST CORP67,39013.9K $as of Mar 31, 2026
XTX Topco Ltd52,99410.9K $as of Mar 31, 2026
LPL Financial LLC33,6276.9K $as of Mar 31, 2026
Vanguard Personalized Indexing Management, LLC31,4926.5K $as of Mar 31, 2026
Corient Private Wealth LLC30,1006.2K $as of Mar 31, 2026
Point72 Asset Management, L.P.29,0386K $as of Mar 31, 2026
Christensen, King & Associates Investment Services, Inc.28,3275.8K $as of Mar 31, 2026
RAYMOND JAMES FINANCIAL INC27,0515.6K $as of Mar 31, 2026
PNC FINANCIAL SERVICES GROUP, INC.25,0005.2K $as of Mar 31, 2026

Declared shareholders of Outlook Therapeutics Inc

There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.

ShareholderDeclared stakeShares
GMS Ventures & Investments and 1 other16.40 %42,631,142as of Aug 12, 2026 · SCHEDULE 13D
CVI Investments, Inc. and 1 other9.90 %24,713,908as of Aug 12, 2026 · SCHEDULE 13G
Cite this page

Titelia. "Fund shareholders of Outlook Therapeutics Inc". https://titelia.com/en/stocks/outlook-therapeutics-inc-US69012T3059